Here are what the editors at HealthDay consider to be the most important developments in Geriatrics for January 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.
FDA Approves First Generic Version of Advair for Asthma, COPD
THURSDAY, Jan. 31, 2019 (HealthDay News) — The first generic form of the Advair Diskus (fluticasone propionate and salmeterol inhalation powder) inhaler has been approved by the U.S. Food and Drug Administration.
AHA: Nearly Half of U.S. Adults Have Cardiovascular Disease
THURSDAY, Jan. 31, 2019 (HealthDay News) — The prevalence of cardiovascular disease (CVD) is 48.0 percent in adults in the United States based on 2013 to 2016 data, according to a report published online Jan. 31 in Circulation.
Small Increase in HbA1c Seen With Switch to Human Insulin in T2DM
THURSDAY, Jan. 31, 2019 (HealthDay News) — Switching from analogue to human insulin is associated with a small increase in hemoglobin A1c (HbA1c) levels, according to a study published in the Jan. 29 issue of the Journal of the American Medical Association.
Abstract/Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)
Aerobic Exercise Tied to Better Cognition at All Ages
WEDNESDAY, Jan. 30, 2019 (HealthDay News) — Aerobic exercise contributes to brain health in individuals as young as 20 years, according to a study published online Jan. 30 in Neurology.
Abstract/Full Text (subscription or payment may be required)
Large Insulin Price Hike to Be Investigated by U.S. Congress
TUESDAY, Jan. 29, 2019 (HealthDay News) — The soaring cost of insulin will be investigated as the U.S. Congress holds hearings into the high cost of prescription drugs, a lawmaker says.
Older Adults With Comorbidities Identified as Frequent ED Users
TUESDAY, Jan. 29, 2019 (HealthDay News) — More than 5 percent of seniors visit emergency departments more than six times in one year, according to a study published online Jan. 28 in the Annals of Emergency Medicine.
Intensive BP Treatment Does Not Reduce Dementia Risk
TUESDAY, Jan. 29, 2019 (HealthDay News) — Treating systolic blood pressure (BP) to a goal of less than 120 mm Hg rather than 140 mm Hg does not result in a significant reduction in the risk for probable dementia, according to a study published online Jan. 28 in the Journal of the American Medical Association.
Evidence Lacking for Benefit of Surgery for Vertebral Fractures
MONDAY, Jan. 28, 2019 (HealthDay News) — Surgical procedures do not appear to provide significant benefit for patients with vertebral fractures (VF), according to a second American Society for Bone and Mineral Research Task Force report published in the January issue of the Journal of Bone and Mineral Research.
Socioeconomic Inequalities Tied to Functional Aging 
Older Adults Limit Movements With Rising Temperatures 
Collagen Supplements Beneficial for Dermal, Bone, Musculoskeletal Health 
Muscular Strength Associated With Lower Mortality in Older Women 
Ultra-Endurance Running Accelerates Red Blood Cell Aging 
Shingles Vaccination May Promote Healthy Aging 
Blood Biomarkers Can Predict Multimorbidity 
Number of Live Births Linked to Biologic Aging, Mortality Risk 
.jpg)